Notes / Company

Shree Ganesh Remedies Ltd.

SGRL BSE 540737 ISIN INE414Y01015 Pharmaceuticals

Fundamentals

Market cap: ₹910 cr
P/E: 51.22×
ROE: 15.89%
Debt / equity: 0.26
52-week range: 381.10 — 759.00

Research on Tijori Finance

Company snapshot

Shree Ganesh Remedies Ltd.

Pharmaceuticals

₹637 cr

P/E 35.25×

Latest quarter · Mar 2026

Sales₹33 cr

Net profit₹6 cr

Op. margin+34.3%

EPS₹4.88

Strength & growth

Debt / equity0.26×

Current ratio3.53×

The timeline — 1 note on Shree Ganesh Remedies Ltd.

May 2026

20 May 26 · 8:21 PM IST Brief

Brief · Earnings · Micro cap

Shree Ganesh Remedies' Q4 call transcript: already old news

The transcript of the May 15 earnings call is now on record, but every material update was already disclosed in the prior concall summary. A routine filing.

Verify on exchange BSE filings for SGRL NSE filings for SGRL Tijori Finance company page